Impact of the CHA 2DS 2-VASc score on anticoagulation recommendations for atrial fibrillation

American Journal of Medicine

Volumn 125, Issue 6, 2012, Pages

  Mason, Pamela K ^a   Lake, Douglas E ^a   Dimarco, John P ^a   Ferguson, John D ^a   Mangrum, J Michael ^a   Bilchick, Kenneth ^a   Moorman, Liza P ^a   Moorman, J Randall ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Anticoagulation; Atrial Fibrillation; Stroke; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN; ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CALCULATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GROUPS BY AGE AND SEX; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RATING SCALE; UNITED STATES; VASCULAR DISEASE; AGE; BLEEDING; CHEMICALLY INDUCED DISORDER; COMORBIDITY; DRUG ADMINISTRATION; EUROPE; HEART FAILURE; METHODOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PREDICTIVE VALUE; PRIMARY PREVENTION; PROPENSITY SCORE; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; SEX DIFFERENCE; STANDARD; STROKE;

ADMINISTRATION, ORAL; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; COMORBIDITY; DIABETES COMPLICATIONS; DRUG ADMINISTRATION SCHEDULE; EUROPE; FEMALE; HEART FAILURE; HEMORRHAGE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PRIMARY PREVENTION; PROPENSITY SCORE; RISK ASSESSMENT; RISK FACTORS; SECONDARY PREVENTION; SEX FACTORS; SOCIETIES, MEDICAL; STROKE; UNITED STATES; WARFARIN;

EID: 84861527172     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.09.030     Document Type: Article

References (20)

1. H.S. Cabin, S. Clubb, C. Hall Risk of systemic embolization of atrial fibrillation without mitral stenosis Am J Cardiol 65 1990 1112 1116
2. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino Impact of atrial fibrillation on the risk of death: the Framingham Heart study Circulation 98 1998 946 952
3. Stroke Prevention in Atrial Fibrillation Investigators Stroke prevention in atrial fibrillation: final results Circulation 84 1991 527 539
4. M.D. Ezekowitz, S.L. Bridgers, K.E. James Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation N Engl J Med 327 1992 1406 1412
5. P. Petersen, J. Godtfredsen, G. Boysen Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study Lancet 333 2003 175 179
6. A.S. Go, E.M. Hylek, Y. Chang Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 290 2003 2685 2692
7. S.J. Connolly, M.D. Ezekowitz, S. Yusuf Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
8. Stroke Risk in Atrial Fibrillation Working Group Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation Stroke 39 2008 1901 1910
9. B.F. Gage, A.D. Waterman, W. Shannon Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
10. V. Fuster, L.E. Rydén, D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - executive summary Circulation 114 2006 700 752
11. M.C. Fang, A.S. Go, Y. Chang ATRIA Study Group Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation J Am Coll Cardiol 51 2008 816 817
12. E.J. Benjamin, D. Levy, S.M. Vaziri Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart study JAMA 271 1994 840 844
13. C.R. Kerr, K. Humphries Gender-related difference in atrial fibrillation J Am Coll Cardiol 46 2005 1307 1308
14. R. Nieuwlaat, A. Capucci, G.Y. Lip Euro Heart Survey Investigators Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation Eur Heart J 27 2006 3018 3026
15. G.Y.H. Lip, R. Nieuwlaat, R. Pisters Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor based approach: the Euro Heart survey on atrial fibrillation Chest 137 2010 263 272
16. A.J. Camm, P. Kirchhof, G.Y.H. Lip Guidelines for the management of atrial fibrillation Euro Heart J 31 2010 2369 2429
17. M. Broukhim, J.L. Halperin Stroke prevention in the high-risk atrial fibrillation patient: medical management Curr Cardiol Rep 13 2011 9 17
18. R.L. McNamara, L.M. Brass, A.S. Drozda Jr American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Data Standards on Atrial Fibrillation) American College of Cardiology; American Heart Association ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Data Standards on Atrial Fibrillation) Circulation 109 2004 3223 3243
19. P.J. Zimetbaum, A. Thosani, H.T. Yu Are atrial fibrillation patients receiving warfarin in accordance with stroke risk? Am J Med 123 2010 446 453
20. N.L. Glazer, S. Dublin, N.L. Smith Newly detected atrial fibrillation and compliance with antithrombotic guidelines Arch Intern Med 167 2007 246 252